biotech · Advanced Solid Tumors · Seasonal Allergic Rhinitis · PRME
Prime Medicine
Prime Medicine is a biotech organization headquartered in Cambridge, USA. It trades on NYSE under ticker PRME. Primary therapeutic focus areas include Advanced Solid Tumors, Seasonal Allergic Rhinitis, Artificial Intelli
60 First St, Cambridge, Massachusetts 02141, US HQ
2019 Founded
185 Employees
Public company Type
PRME · NYSE Ticker
Company details
- Status
- Public
- HQ
- 60 First St, Cambridge, Massachusetts 02141, US
- Founded
- 2019
- Employees
- 185
- Programs
- 17
- Drugs
- 6
- Patents
- 127
FP-1039
Phase 2 · small molecule · Endometrial Cancers With FGFR2 Mutations
FP-1039 for Endometrial Cancers With FGFR2 Mutations is a Phase 2 program (small_molecule) at Prime Medicine with 1 ClinicalTrials.gov record(s).
Internal code FP1039-002
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Prime Medicine
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Endometrial Cancers With FGFR2 Mutations
- Status
- terminated
- Trials
- 1